4//SEC Filing
Shrivastava Sanjay 4
Accession 0001493152-18-016879
CIK 0001661053other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 5:31 PM ET
Size
7.9 KB
Accession
0001493152-18-016879
Insider Transaction Report
Form 4
Shrivastava Sanjay
Director
Transactions
- Award
Restricted Stock units
2018-11-27$2.57/sh+29,183$75,000→ 29,183 total - Award
Stock Options
2018-11-27+60,000→ 60,000 totalExercise: $2.57Exp: 2021-10-02→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]The Restricted Stock Units ("RSUs") were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to the Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) October 2, 2019; (ii) October 2, 2020; and (iii) October 2, 2021.
- [F2]Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A.
- [F3]The common stock options were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to a grant under the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (the "Plan"), as amended. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from October 2, 2018.
Documents
Issuer
Hancock Jaffe Laboratories, Inc.
CIK 0001661053
Entity typeother
Related Parties
1- filerCIK 0001754588
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 5:31 PM ET
- Size
- 7.9 KB